Clean Diesel Technologies, Inc.
- --------------------------------------------------------------------------------
300 ATLANTIC STREET, SUITE 702, STAMFORD, CT 06901-2522 TEL: (203) 327-7050
FAX: (203) 323-0461
NEWS RELEASE FORAUGUST 8, 2005 AT 2:30 AM EST AND 7:30 AM GMT
- -------------------------------------------------------------
Contact: ALLEN & CARON IN or CLEAN DIESEL TECHNOLOGIES, INC.
Jesse E. Deal (US investors) James M. Valentine, President
(212) 691-8087; jesse@allencaron.com (203)-327-7050; jvalentine@cdti.com
Len Hall (US media) David W. Whitwell, CFO
(949) 474-4300; len@allencaron.com (203) 327-7050; dwhitwell@cdti.com
ABCHURCH COMMUNICATIONS
Heather Salmond (UK investors) +44 (0)20 7398 7700
heather.salmond@abchurch-group.com
DR. WALTER COPAN APPOINTED VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER OF CLEAN
DIESEL TECHNOLOGIES, INC.
STAMFORD, CT (AUGUST 8, 2005) Clean Diesel Technologies, Inc. (CDT)
(EBB:CDTI & AIM:CDT/CDTS) a developer of chemical and technological solutions to
reduce harmful engine emissions, announced today that effective August 3, 2005,
Walter Copan, Ph.D., has been appointed Vice President and Chief Technology
Officer.
"Hiring a proven leader like Dr. Copan is an important step for the growth
of CDT as a technology company," said Bernhard Steiner, CEO. "Dr. Copan is an
excellent addition to the Clean Diesel team as he brings strong environmental
and chemical experience to the Company."
Most recently Dr. Copan was Principal Licensing Executive, Technology
Transfer, for the U.S. Department of Energy's National Renewable Energy
Laboratory (NREL) based in Golden, CO. NREL is the DOE's premier laboratory for
energy efficiency and renewable energy research. At NREL, Dr. Copan was
responsible for commercialization of clean energy, energy efficiency and related
technologies, through partnerships with industry, academia, and government.
Prior to joining NREL, Dr. Copan was Managing Director, Technology Transfer
and Licensing for The Lubrizol Corporation. Previous assignments in Dr. Copan's
28 year career with Lubrizol include a variety of leadership roles in research,
development and engineering, product development, strategy, international
business development and new ventures. He also headed Lubrizol Petroleum
Chemicals Technology based in the U.K., with responsibility for product
development, program management and technical service for Europe, the Middle
East, Africa and the Former Soviet Union.
Commenting on his appointment, Dr. Copan said: "It is a pleasure to be
joining Clean Diesel and to work with the Company's partners to bring proven
technologies for energy efficiency, environment protection and renewable fuels
to the global transportation and distributed power markets. I have been
privileged to make an impact for NREL and the U.S. DOE during recent times of
heightened focus on energy security, climate change and the environment, and I
look forward to applying this experience in my new role."
MORE-MORE-MORE
COPAN APPOINTED VP AND CTO OF CLEAN DIESEL TECHNOLOGIES, INC
Page 2-2-2
Copan received his Ph.D. in Physical Chemistry from Case Western Reserve
University, and his undergraduate degrees from CWRU are in chemistry and music.
He is member of the Board of the Licensing Executives Society (LES) and also
serves as member of the National Advisory Council to the U.S. Federal Laboratory
Consortium.
About Clean Diesel Technologies, Inc.
- -------------------------------------
Clean Diesel Technologies, Inc. and its UK representative office, Clean
Diesel International LLC, is a developer of chemical and technological solutions
to reduce harmful engine emissions. Clean Diesel Technologies has patented
products that reduce emissions from combustion engines while simultaneously
improving fuel economy and power. Products include Platinum Plus(R) fuel borne
catalysts, the Platinum Plus Purifier System and the ARIS(R) 2000 urea injection
systems for selective catalytic reduction of NOx. Platinum Plus and ARIS are
registered trademarks of Clean Diesel Technologies, Inc. For more information,
visit CDT at www.cdti.com or contact the Company directly.
Certain statements in this news release constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. Such forward-looking statements involve known or unknown risks,
including those detailed in the Company's filings with the Securities and
Exchange Commission, uncertainties and other factors which may cause the actual
results, performance or achievements of the Company, or industry results, to be
materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof.